0000908662-16-000389.txt : 20160114 0000908662-16-000389.hdr.sgml : 20160114 20160114161448 ACCESSION NUMBER: 0000908662-16-000389 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160112 FILED AS OF DATE: 20160114 DATE AS OF CHANGE: 20160114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 BUSINESS PHONE: 617-250-5769 MAIL ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BLAIR HENRY E CENTRAL INDEX KEY: 0001021045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24537 FILM NUMBER: 161343116 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-01-12 0000907562 DYAX CORP DYAX 0001021045 BLAIR HENRY E C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803-2756 1 0 0 0 Common Stock 2016-01-12 4 M 0 70000 2.94 A 421722 D Common Stock 2016-01-12 4 M 0 50000 2.39 A 471722 D Common Stock 2016-01-12 4 M 0 50000 2.09 A 521722 D Common Stock 2016-01-12 4 M 0 50000 3.15 A 571722 D Common Stock 2016-01-12 4 M 0 50000 2.09 A 621722 D Common Stock 2016-01-12 4 M 0 25000 1.51 A 646722 D Common Stock 2016-01-12 4 M 0 51414 2.06 A 698136 D Common Stock 2016-01-12 4 M 0 117646 2.06 A 815782 D Common Stock 2016-01-12 4 M 0 117646 2.06 A 933428 D Common Stock 2016-01-12 4 M 0 66667 2.30 A 1000095 D Common Stock 2016-01-12 4 M 0 16667 26.23 A 1016762 D Common Stock 100 I By wife Stock Option (right to buy) 2.94 2016-01-12 4 M 0 70000 0 D 2016-07-03 Common Stock 70000 0 D Stock Option (right to buy) 2.39 2016-01-12 4 M 0 50000 0 D 2019-02-11 Common Stock 50000 0 D Stock Option (right to buy) 2.09 2016-01-12 4 M 0 50000 0 D 2019-05-14 Common Stock 50000 0 D Stock Option (right to buy) 3.15 2016-01-12 4 M 0 50000 0 D 2020-05-06 Common Stock 50000 0 D Stock Option (right to buy) 2.09 2016-01-12 4 M 0 50000 0 D 2021-05-12 Common Stock 50000 0 D Stock Option (right to buy) 1.51 2016-01-12 4 M 0 25000 0 D 2022-05-09 Common Stock 25000 0 D Stock Option (right to buy) 2.06 2016-01-12 4 M 0 51414 0 D 2017-06-20 Common Stock 51414 0 D Stock Option (right to buy) 2.06 2016-01-12 4 M 0 117646 0 D 2017-07-02 Common Stock 117646 0 D Stock Option (right to buy) 2.06 2016-01-12 4 M 0 117646 0 D 2018-02-13 Common Stock 117646 0 D Stock Option (right to buy) 2.30 2016-01-12 4 M 0 66667 0 D 2023-05-09 Common Stock 66667 8333 D Stock Option (right to buy) 26.23 2016-01-12 4 M 0 16667 0 D 2025-05-12 Common Stock 16667 8333 D The options became fully exercisable on July 3, 2010. The options became fully exercisable on May 14, 2009. The options became fully exercisable on May 14, 2010. The options became fully exercisable on May 12, 2011. The options became fully exercisable on May 9, 2012. The options became fully exercisable on May 9, 2013. The options became fully exercisable on May 8, 2014. The option becomes exercisable in thirty-six (36) substantially equal installments at the end of each monthly anniversary of the date of grant (May 9, 2013) for a period of thirty-five (35) months, with the 36th monthly installment to become exercisable as of the commencement of business on the date of the 2016 Annual Meeting of Stockholders at which such director is up for reelection or at which such director's term ends. The option becomes exercisable in twelve (12) substantially equal installments on each monthly anniversary of the date of grant, May 12, 2015. /s/ Stacie S. Aarestad as attorney-in-fact 2016-01-14